Evidence map›Paper›PMID 40665123›Full record

ArticleJournal of computer-aided molecular design2025

Mechanistic insights into PROTAC-mediated degradation through an integrated framework of molecular dynamics, free energy landscapes, and quantum mechanics: A case study on kinase degraders.

Ashis Nandy, Kiran Boppana, Samiron Phukan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. MPS1 inhibition as an anticancer strategy: where do we stand?Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2026
    Review
  2. Article
  3. Protein-Protein Interactions with the Fragment Molecular Orbital Method.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ashis NandyIntegrated Drug Discovery, Aragen Lifesciences Ltd, Hyderabad, 500076, India.
Kiran BoppanaIntegrated Drug Discovery, Aragen Lifesciences Ltd, Hyderabad, 500076, India.
Samiron PhukanIntegrated Drug Discovery, Aragen Lifesciences Ltd, Hyderabad, 500076, India. samiron.phukan@aragen.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeted protein degradation by proteolysis-targeting chimeras (PROTAC) is dependent on formation and plasticity of ternary complexes enabling ubiquitination. In this study, we employed long-timescale molecular dynamics (MD) simulations, free energy landscape analysis, and quantum mechanical (QM) calculations to investigate the molecular determinants of PROTAC efficacy. Using three model systems (FAK-VHL, BTK-CRBN, and TTK-CRBN), each with three PROTACs of varying potencies, we analyzed a total of nine ternary complexes over 500 ns MD simulations each. Simulation events analysis revealed that potent PROTACs maintain stable and important interactions between the protein of interest (POI) and the E3 ligase, while weaker PROTACs exhibit diminished or no interactions. Conformational dynamics and changes in the interaction patterns between the POI-E3-ligase complexes highlighted the importance of ternary complex plasticity in degradation efficiency. These findings were also supported by the distribution of free energy landscape during simulations. Distributions of the free energy landscape offer insights into the stability of population states and open new avenues for understanding their degradation potential. Additionally, to overcome the limitation of conventional docking models, we highlight the importance of QM and DFT based methods to predict the impact of binding at the E3-ligase site which corelates with the degradation potentials of PROTACs. These insights provide a new computational framework for rational PROTAC design.

Indexed as

Molecular Dynamics SimulationProteolysisUbiquitin-Protein LigasesHumansProtein BindingQuantum MechanicsQuantum TheoryThermodynamicsUbiquitinationUbiquitin-Protein LigasesBTKFAKFree energy landscapeMD simulationPROTACsQM calculationsTTK

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.